Change in disability after one year · patients with chronic inflammatory demyelinating polyradiculoneuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Remission · patients with chronic inflammatory demyelinating polyradiculoneuropathy
Monthly pulsed high‐dose dexamethasone probably leads to higher remission at 12 months compared with oral prednisolone (moderate certainty).
1 finding from 1 review
≥ 1 point improvement on INCAT disability score at 12 months · patients with chronic inflammatory demyelinating polyradiculoneuropathy
Monthly pulsed high‐dose dexamethasone may leads to higher ≥ 1 point improvement on INCAT disability score at 12 months compared with oral prednisolone (low certainty).
1 finding from 1 review
Change in MRC sum score · patients with chronic inflammatory demyelinating polyradiculoneuropathy
1 finding from 1 review
Participant‐reported musculoskeletal pain, discomfort or fatigue Method: 0‐100 mm VAS · office workers
1 finding from 1 review
Productivity or work performance Method: number of words typed per 3 hours · office workers
1 finding from 1 review
Improvement in symptoms · GORD in children over 1 year of age
1 finding from 1 review
Adverse events · GORD in children over 1 year of age
1 finding from 1 review
Improvement in pH indices ‐ not measured · GORD in children over 1 year of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Endoscopic metrics ‐ not measured · GORD in children over 1 year of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Alertness · daytime workers
1 finding from 1 review
no estimate extracted
163 participants
Very low
Mood (positive) · daytime workers
1 finding from 1 review
no estimate extracted
94 participants
Very low
Mood (negative) · daytime workers
1 finding from 1 review
no estimate extracted
94 participants
Very low
Adverse events ‐ eye discomfort · daytime workers
1 finding from 1 review
no estimate extracted
94 participants
Very low
All‐cause mortality · people with or without existing CVD, men and women
Higher polyunsaturated fatty acid (PUFA) showed no clear difference in all‐cause mortality compared with lower PUFA (moderate certainty).
1 finding from 1 review
Adiposity · people with or without existing cardiovascular disease, men and women
1 finding from 1 review
Cholesterol mg/dL · people with or without existing cardiovascular disease, men and women
1 finding from 1 review
Serum fasting triglyceride (TG, mmol/L) · people with or without existing cardiovascular disease, men and women
1 finding from 1 review
Serum low‐density lipoprotein (LDL, mmol/L) · people with or without existing cardiovascular disease, men and women
1 finding from 1 review
CHD events · people with or without existing CVD, men and women
Higher polyunsaturated fatty acid (PUFA) showed no clear difference in coronary heart disease events compared with lower PUFA (moderate certainty).
1 finding from 1 review